📰 Reduced Time News
Reduced Time News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Reduced Time. Real-time updates on events, politics, business and more.
April 24, 2024
The Remnant 2 update 1.000.028 patch notes have been announced by Gunfire Games. Find out what's new with Remnant 2 on PS5 here.
June 15, 2023
EdgeCore’s Digital Twin Solution Drives Increased AI/ML Accuracy and Time to ValueARLINGTON, Va., June 15, 2023 -- Edge Technologies, Inc. the operating company of Edge Total Intelligence... | June 15, 2023
November 8, 2022
/PRNewswire/ -- The "Global Enzymes Market by Product Type (Industrial enzymes and Specialty Enzymes), Source (Microorganism, Plant, and Animal), Type,...
May 12, 2021
Building Restoration Market Outlooks 2021: Industry Analysis, Top Companies, Growth rate, Cost Structures and Opportunities to 2025
March 15, 2021
AcelRx Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results Full year 2020 revenues of $5.4 million compared to $2.3 million in 2019 News provided by Share this article Share this article REDWOOD CITY, Calif., March 15, 2021 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today reported its fourth qua...
February 24, 2021
Gov. Andy Beshear has recommended all Kentucky schools resume or expand in-person classes starting Monday now that the COVID-19 infection rate has dropped. Beshear made the recommendation in an executive order this week that calls for resumption of face-to-face instruction while maintaining pandemic safety precautions such as masking and social distancing. âItâs going to be incredibly important, especially for districts that may go back for the first time, that this is strictly enforc...
January 14, 2021
Share this article Share this article REDWOOD CITY, Calif., Jan. 14, 2021 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced preliminary unaudited financial results and other information in connection with its participation in investor presentations, meetings and events during the week of the 39 th Annual J.P. Morgan Hea...